ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Clarifies P01 Grant Application Dates

September 13, 1996

NCCN Publishes Anemia Guidelines

April 12, 2002

Bills Introduced To Raise Cigarette Excise Tax By Bradley, Andrews

March 12, 1993

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011

Funding Opportunities: NCI Grant Supplements For Mammalian Models

October 22, 1999

Non-Invasive Test May Detect Lung Cancer In Early Stages

September 26, 2003